The company offers a modular microbial engineering platform that designs, builds, and optimizes production strains to convert renewable feedstocks into commodity and specialty chemicals. It integrates CRISPR‑based genome editing, AI‑driven metabolic pathway prediction, high‑throughput strain screening, and cloud‑based process analytics to deliver scalable, low‑energy biocatalytic routes that meet industrial throughput and regulatory standards.
Funding
Funding not disclosed
Founders
Product
Problem
Industrial chemical synthesis relies heavily on fossil‑derived feedstocks and energy‑intensive processes, leading to high carbon emissions and waste streams. Existing biomanufacturing approaches often lack the scalability, specificity, or robustness required for large‑volume commodity and specialty chemicals.
Solution
The company provides a modular microbial engineering platform that designs, builds, and optimizes production strains for targeted chemical transformations. Using CRISPR‑based genome editing combined with AI‑driven metabolic pathway prediction, they accelerate the creation of cell factories that convert renewable substrates into high‑value intermediates. Their workflow integrates high‑throughput strain screening, adaptive laboratory evolution, and scalable fed‑batch fermentation to ensure consistent yields at commercial scale. Process data are streamed to a cloud analytics suite that monitors key performance indicators in real time and suggests iterative improvements. The resulting biomanufacturing routes replace petrochemical steps with low‑energy, waste‑reduced biocatalysis, enabling customers to meet sustainability targets without sacrificing throughput.
Target Audience
Primary customers are industrial chemical producers, specialty chemicals manufacturers, and pharmaceutical companies seeking to replace petrochemical steps with bio‑based processes at scale. The platform also serves contract development and manufacturing organizations (CDMOs) that require rapid, custom strain development for niche market applications.
Features
- CRISPR/Cas9 and base‑editing toolkits for precise, multiplexed genome modifications in bacteria, yeast, and filamentous fungi
- Machine‑learning models that predict pathway fluxes and suggest gene targets to maximize product titer and productivity
- Automated high‑throughput micro‑fermentation platform for rapid phenotype screening of thousands of engineered strains
- Scalable bioreactor designs with integrated process analytical technology (PAT) for real‑time monitoring of pH, dissolved oxygen, and metabolite concentrations
- Modular plasmid library containing curated, IP‑free enzymes for common functional group transformations (e.g., oxidation, reduction, amination)
- End‑to‑end data pipeline that links strain genotype, fermentation parameters, and downstream purification metrics to a cloud‑based dashboard
- Regulatory‑compliant documentation package (GMP, ISO 9001) to accelerate technology transfer to manufacturing sites